Drawing for CINVENTOR

USPTO serial 79039824

CINVENTOR

Reviewed by CopyMark Law Group

Reg. 3676545Status 404
Filing date
Status date
Registration date
Sep 1, 2009
Examiner
BROWNE, DAYNA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CINVENTOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Schweltzer Comman

Schweltzer Comman Ladas & Parry LLP26 West 61st StreetAtt: Michael A. Cornman, Meyer A. GrossNew York, NY 10023

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for use in industry and science, in particular substrates and coating compounds used in chemical process technology, biological process technology, namely, polymer coatings for use in the manufacture of pharmaceutical preparations and medical devices, peptide substrates, enzyme substrates and polymer substrates for use in the manufacture of pharmaceutical preparations and medical devicesSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary products, namely, substrates in the nature of biocompatible materials suitable to carry cells and/or drugs used for cells and tissues, implant materials comprising living tissue, enzymes, antibodies, growth factors and pharmaceutical agents, namely, agents for diagnostic applications or therapeutic treatment in the field of cancer, opthalmology, haematology, geneacology, orthopedy, neurology, neurosurgery, rheumatology, otolaryngology, cardiology, all for medical purposes; surgical implants, namely, grafts and stents of all types comprising living tissue, enzymes, antibodies, growth factors or pharmaceutical agents, namely, agents for diagnostic applications or therapeutic treatment in the field of cancer, opthalmology, haematology, geneacology, orthopedy, neurology, neurosurgery, rheumatology, otolaryngology, cardiology, all for medical purposesSECTION 71 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, catheter, intracardiac catheter; medical, surgical and orthopaedic implants, namely, stent, screws, nails, plates, customized shaped implants to repair or fill gaps and defects in bone, implants replacing parts of bones, and joints made of artificial materials, endoprosthesis, stents of all types, in particular for support or extension of blood vessels; biocompatibly coated stents, bone or joint prosthesis; artificial hearts and parts thereof, artificial cardiac valves; cardiac pacemaker; suture materialSECTION 71 - CANCELLED—
042Development of substrates for cells or living tissue in biological process technology; development of substrate systems, membrane and separating technology for chemical process technologySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2017UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Nov 10, 2017DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 10, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 28, 2017INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 11, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 11, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 8, 2016INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 8, 2016C71TCANCELLED SECTION 71—
Jan 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 18, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 18, 2009FIMPFINAL DISPOSITION PROCESSED—
Dec 1, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 1, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2009NPUBNOTICE OF PUBLICATION—
May 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 1, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 1, 2009EXPIEX PARTE APPEAL-INSTITUTED—
May 1, 2009JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
May 1, 2009EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Mar 24, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2009ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 3, 2008CFRCSUBSEQUENT FINAL MAILED—
Nov 3, 2008CFRCSUBSEQUENT FINAL MAILED—
Nov 2, 2008CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
Sep 29, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2008ALIEASSIGNED TO LIE—
Sep 23, 2008ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 25, 2008CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jul 3, 2008LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 5, 2008CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Apr 24, 2008CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Mar 31, 2008CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 29, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 7, 2008LIECLEGAL INSTRUMENT EXAMINER (LIE) - CORRECTION—
Mar 6, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 6, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2008ALIEASSIGNED TO LIE—
Feb 4, 2008MAILPAPER RECEIVED—
Sep 1, 2007RFNPREFUSAL PROCESSED BY IB—
Aug 10, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 10, 2007RFRRREFUSAL PROCESSED BY MPU—
Aug 9, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 8, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2007DOCKASSIGNED TO EXAMINER—
Jul 20, 2007NWAPNEW APPLICATION ENTERED—
Jul 19, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance